Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino]ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent

Journal of Nuclear Medicine

Volumn 34, Issue 1, 1993, Pages 30-38

  Higley, B ^a   Smith, F W ^a   Smith, T ^a   Gemmell, H G ^a   Gupta, P D ^a   Gvozdanovic, D V ^a   Graham, D ^a   Hinge, D ^a   Davidson, J ^a   Lahiri, A ^a  

^a GENERAL ELECTRIC COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMERTEC II; P 53; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TETROFOSMIN; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSIMETRY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MIXTURE; DRUG SAFETY; DRUG UPTAKE; EXERCISE; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REST;

HEART; HUMAN; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGE; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIATION DOSAGE; TISSUE DISTRIBUTION;

EID: 0027514338     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)